Key Advantage
One drop! 3 minutes!
With a simple 3 step operation and a wide range of disease markers, the system supports quick decision-making.
It is expected to increase patients’ satisfaction and a hospital’s profitability by improving the effectiveness the test.
Key Technology
Microfluidics Technology Leader
The FREND™ System is an in vitro diagnostic device that uses microfluidics technology and immunofluorescent techniques.
Disposable plastic microfluid chip continuously mixes, reacts, separates, and quantitative analysis on the chip.
This is a source technology that is the foundation for bioengineering experiments and point-of-care test (POCT).
ADVANTAGE 01
Excellent Quality Control
Use the QC cartridge to quickly check the integrity of the system. The FREND™ System cleared 510(k) as the in vitro diagnostic (IVD).
The code chip significantly reduces possible errors in between test values and LOT variation, hence provides more accurate results.
ADVANTAGE 02
Superior Accuracy
The FREND™ System received FDA 510(k) clearance as the in-vitro diagnostics
which provides a high correlation with large machinery and provides accurate results.
ADVANTAGE 03
FDA 510(k) clearance
PSA Plus, TSH, Free T4, Testosterone and Vitamin D cleared from FDA 510(k).
FREND™ System provides a variety of other inspection items, which can be tested for a total of 12 different types.
including BNP, Troponin I, Cardiac Triple, PCT, Total T3, and Thyroid Duo.
| Product name / Cat. No. | FREND™ System / F10 |
|---|---|
| Electrical rating | 100-240 V~, 1.7 A, 50/60 Hz |
| Output | DC 12 V, 3.33 A |
| Dimension | 240 mm x 260 mm x 175 mm (W x L x H) |
| Operating Condition | 10~40 °C (Temperature) / 30~80 % (Humidity) |
| Storage condition | 15~30 °C (Temperature) / 10~80 % (Humidity) |
| User interface | 7-inch touch screen |
| Printer size | 75 mm x 103 mm x 44.3 mm |
| Printer weight | 200 g |
| Printing speed | 50 mm/sec |
| Weight | 3 Kg |